ATE235910T1 - Isoliertes material mit anti-organotropischer wirkung - Google Patents

Isoliertes material mit anti-organotropischer wirkung

Info

Publication number
ATE235910T1
ATE235910T1 AT99972922T AT99972922T ATE235910T1 AT E235910 T1 ATE235910 T1 AT E235910T1 AT 99972922 T AT99972922 T AT 99972922T AT 99972922 T AT99972922 T AT 99972922T AT E235910 T1 ATE235910 T1 AT E235910T1
Authority
AT
Austria
Prior art keywords
organotropic
effect
insulated material
mammalian
physico
Prior art date
Application number
AT99972922T
Other languages
English (en)
Inventor
John Ernest Hart
Original Assignee
Endocrine Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endocrine Pharmaceuticals Ltd filed Critical Endocrine Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE235910T1 publication Critical patent/ATE235910T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Liquid Crystal Substances (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
AT99972922T 1998-12-01 1999-12-01 Isoliertes material mit anti-organotropischer wirkung ATE235910T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9826186.0A GB9826186D0 (en) 1998-12-01 1998-12-01 Chemical compound
PCT/GB1999/004013 WO2000032208A2 (en) 1998-12-01 1999-12-01 Isolated material having an anti-organotrophic effect

Publications (1)

Publication Number Publication Date
ATE235910T1 true ATE235910T1 (de) 2003-04-15

Family

ID=10843297

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99972922T ATE235910T1 (de) 1998-12-01 1999-12-01 Isoliertes material mit anti-organotropischer wirkung

Country Status (14)

Country Link
US (2) US7572465B1 (de)
EP (1) EP1135145B1 (de)
JP (1) JP2002531410A (de)
AT (1) ATE235910T1 (de)
AU (1) AU758592B2 (de)
CA (1) CA2353590A1 (de)
DE (1) DE69906575T2 (de)
DK (1) DK1135145T3 (de)
ES (1) ES2192419T3 (de)
GB (1) GB9826186D0 (de)
NZ (1) NZ512123A (de)
PT (1) PT1135145E (de)
WO (1) WO2000032208A2 (de)
ZA (1) ZA200104487B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0014029D0 (en) * 2000-06-08 2000-08-02 Endocrine Pharmaceuticals Limi Isolated material having size-inhibitory effects on cells,tissues and organs
WO2009087424A2 (en) 2008-01-10 2009-07-16 Endocrine Pharmaceuticals Limited Proteinaceous compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734398A (en) * 1983-03-15 1988-03-29 University Of Southern California Follicular regulating protein

Also Published As

Publication number Publication date
EP1135145B1 (de) 2003-04-02
US7572465B1 (en) 2009-08-11
US20050244507A1 (en) 2005-11-03
PT1135145E (pt) 2003-07-31
GB9826186D0 (en) 1999-01-20
WO2000032208A3 (en) 2000-10-19
ES2192419T3 (es) 2003-10-01
DE69906575D1 (de) 2003-05-08
AU758592B2 (en) 2003-03-27
NZ512123A (en) 2003-02-28
DE69906575T2 (de) 2003-12-11
JP2002531410A (ja) 2002-09-24
AU1399500A (en) 2000-06-19
US7700132B2 (en) 2010-04-20
CA2353590A1 (en) 2000-06-08
DK1135145T3 (da) 2003-06-23
WO2000032208A2 (en) 2000-06-08
ZA200104487B (en) 2002-07-25
EP1135145A2 (de) 2001-09-26

Similar Documents

Publication Publication Date Title
DE69429878D1 (de) Resorbierbarer gefässwundenverband
EP1100535A4 (de) Gezielte zufuhr von pharmazeutischen agenzien zu verletzten geweben
ATE198980T1 (de) Bioabbaubare polymere zur zelltransplantation
DK480284D0 (da) Sporstofmaerkede konjugater af metallothionein og maalsoegende, biologisk aktive molekyler
DE69831566T2 (de) Probucol monoester zur behandlung von kreislauf- und entzündungserkrankungen
DE69528058D1 (de) Bmp-9 zusammensetzungen
PT1200105E (pt) Factor viii modificado
CA2213533A1 (en) Resorbable extracellular matrix for reconstruction of cartilage tissue
DE69637395D1 (de) Moleküle, die sich in ausgewählten Organen oder Geweben in-vivo einfinden
CY1115496T1 (el) Νευροτροφικος αυξητικος παραγοντας
BR9206736A (pt) Composição para afetar o crescimento de tecido vivo em mamíferos processos para promover a angiogenese em mamíferos para tratar tecido transplantado ou órgãos em mamíferos e para tratar osso danificado ou transplantado
DE69527749D1 (de) Kugelförmige Aktivkohle zur Behandlung von Bauchentzündungen
NO982721L (no) Preserverende oppl°sning
DE60001555D1 (de) Wässrige lösung zum konservieren von gewebe und organen
NO932101L (no) Polypeptidmateriale som er anvendelig ved terapeutisk behandling av mennesker
DE60313356D1 (de) Verwendungvon dextransulfat zur behandlung von ibmir
HUP9901188A2 (hu) Új, meghatározott enzimkeverékek sejtkinyeréshez és sebkezeléshez
CA2212563A1 (en) Process for obtaining medically active fractions from sea cucumbers
DE69630879D1 (de) Biologisch abbaubare vorrichtung
ATE235910T1 (de) Isoliertes material mit anti-organotropischer wirkung
ATE234862T1 (de) Glycoproteine mit lipidmobilisierenden eigenschaften und deren therapeutische verwendungen
DE69726883D1 (de) Magnetotherapeutische vorrichtung
DE69922174D1 (de) Biomaterial zur behandlung von zahnfäule
ATE306929T1 (de) Inositolphosphoglycan und ribose zur behandlung von ischämischen-reperfusionschaden
ATE42201T1 (de) Verwendung von phytosterolglycosiden zur herstellung von arzneimitteln zur behandlung von erhoehtem 5(6)alpha-epoxycholesterolgehalt.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1135145

Country of ref document: EP

REN Ceased due to non-payment of the annual fee